MedTrace Logo

Reappraisal of Atrial Fibrillation: RACE-V - Work Package 5

NCT03124576 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 380

Last updated 2018-07-19

No results posted yet for this study

Summary

In the proposed study the investigators aim to clarify the relative contribution of these different mechanisms to the progression of atrial fibrillation (AF). Also the contribution of the individual genetic background will be investigated. Furthermore, the investigators aim to identify clinical parameters and biomarkers informing on the main mechanisms of AF progression in atrial tissue.

For this purpose, in all included patients atrial biopsies will be taken during cardiac surgery.

Conditions

Interventions

DEVICE

Implantable loop recorder

Continuous rhythm monitoring Medtronic

Sponsors & Collaborators

  • Academisch Ziekenhuis Maastricht

    lead OTHER

Principal Investigators

  • Jos Maessen, Prof. Dr. · Academisch Ziekenhuis Maastricht

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-30
Primary Completion
2021-10-31
Completion
2021-10-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03124576 on ClinicalTrials.gov